Senior insider sale
President and CEO at MADRIGAL PHARMACEUTICALS, INC. — senior position signals high conviction
$4.64M
9.68K shares
What this filing means
SIBOLD WILLIAM JOHN plans to sell 9.68K shares of MADRIGAL PHARMACEUTICALS, INC. valued at approximately $4.64M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/4/2025ACC: 0001628280-25-055416
DirectorOfficer· President and CEO
Since Mar 2026
9.68K
Shares to sell
$4.64M
Approx. market value
2.40K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Performance Restricted Stock Unit Grant
Vesting of Performance Restricted Stock Units
12/3/2025
2.40KTotal acquired2.40K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/3/2025 | Performance Restricted Stock Unit Grant Vesting of Performance Restricted Stock Units | 2.40K | — |
| Total | 2.40K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
7.28K
Market value
$3.24M
9/9/2025
Planned — Approximate Date
Nasdaq Stock MarketPlanned
Units to sell
2.40K
Market value
$1.39M
12/4/2025
Total
Units
9.68K
Value
$4.64M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/9/2025 | 7.28K | $3.24M | — | Completed |
| Planned — Approximate Date | ||||
12/4/2025 | 2.40K | $1.39M | Nasdaq Stock Market | Planned |
| Total | 9.68K | $4.64M | ||